Moreover, the cardioprotective properties of GLP-1 RAs have been manifested in terms of reducing hypertension, hyperlipidemia, and cardiac arrythmias; controlling these factors plays a key role in the CV risk mitigating strategies. This evidence concerns the gene GLP1R and Hypertension.